Flotetuzumab Uses, Dosage, Side Effects and more
Flotetuzumab is under investigation in clinical trial NCT02152956 (Safety Study of MGD006 in Relapsed/Refractory Acute Myeloid Leukemia (AML) or Intermediate-2/High Risk MDS).
| Trade Name | Flotetuzumab |
| Generic | Flotetuzumab |
| Flotetuzumab Other Names | Flotetuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
